Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

HSBC analyst Frank Lee sees that trend continuing, and lowered his price target on AMD shares by $90, to $110 per share, and ...

Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...

On Monday at CES 2025, Nvidia unveiled a desktop computer called Project DIGITS. The machine uses Nvidia's latest 'Blackwell' ...

Micron Technology, Inc. MU shares rose 2.7% on Tuesday following NVIDIA Corporation’s NVDA announcement that Micron would be ...

Among Nvidia, Apple, Microsoft, Amazon, Alphabet, Meta Platforms, and Tesla, there's a phenomenal bargain hiding in plain ...

In a note to clients on Sunday, Jefferies analyst Steven G. DeSanctis estimated that for 2025, the Sweet 16 would show an aggregate earnings increase of 21.5%, with a median increase of 15.8%. For the ...

As a result, the stock finished the month down 17%, according to data from S&P Global Market Intelligence. As you can see ...

The MSI Vanguard graphics card debuts as MSI’s latest high-end series, crafted for gamers who demand premium performance and ...

On price alone, AMD has a leg up on Nvidia. AMD offers more affordable graphics card options, focusing on the budget and ...

Leading processor and AI graphics processing unit provider join forces to advance processing and connectivity in sector where ...